Video

Dr. Wingo on the Evolution of Surgery in Endometrial Cancer

Author(s):

Shana Wingo, MD, gynecologic oncologist, Arizona Oncology, discusses the evolution of surgery in endometrial cancer.

Shana Wingo, MD, gynecologic oncologist, Arizona Oncology, discusses the evolution of surgery in endometrial cancer.

Gynecologic oncology is extremely complex—it is a melding of multiple concentrations into 1 specialty, says Wingo. Advanced surgical training for gynecologic oncology includes more complex surgeries in the upper abdomen. One thing that has persisted over time and remains true to this day, Wingo says, is that the amount of residual disease affects survival. Surgical knowledge and skills need to be improved and modified as time goes on so that the field is continuing to provide the best outcomes.

Surgery for patients with endometrial cancer has changed drastically in the past 20 years, Wingo explains. Surgeons often performed open surgeries in the past, whereas now, 80% to 90% of cases are minimally invasive. Through proper development, Wingo believes that there is a chance that the technique of minimally invasive surgery can be perfected. If that proves to be true, patients will experience quicker recoveries, which will allow clinicians to administer the next line of therapy sooner.

Related Videos
Paolo Caimi, MD
Dr Oveisi on the Importance of Patient Counseling Prior to CAR T-Cell Therapy in Myeloma
Leo I. Gordon, MD
Janaki Neela Sharma, MD, University of Miami
Richard Kim, MD, Moffitt Cancer Center
Janaki Neela Sharma, MD, discusses CheckMate 901, and where nivolumab plus chemotherapy fits into the advanced urothelial cancer treatment paradigm.
David Rimm, MD, PhD, discusses current HER2 immunohistochemistry assays that are used in the management of breast cancer, and their shortcomings.
Jennifer Scalici, MD
Steven H. Lin, MD, PhD
Farrukh Awan, MD, discusses treatment considerations with the use of pirtobrutinib in previously treated patients with hematologic malignancies.